CUSIP 00650F109 · who reports it, how much, and how much it matters to them
25 of the 720 hedge fund managers we track reported shares of Adaptive Biotechnologies Corp (Nasdaq: ADPT) on Form 13F for 30 June 2026. Between them they reported USD 875m. The largest position belongs to Viking Global Investors, at USD 643m. The manager with the most riding on it is Blue Water Life Science Advisors, where it is 13.6% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Viking Global Investors4 funds on PPLI.com | USD 643m | 1.8% |
| 2 | D. E. Shaw & Co.15 funds on PPLI.com | USD 99m | 0.0% |
| 3 | Perceptive Advisors6 funds on PPLI.com | USD 26m | 0.4% |
| 4 | Blue Water Life Science Advisors3 funds on PPLI.com | USD 22m | 13.6% |
| 5 | Freestone Grove Partners1 fund on PPLI.com | USD 19m | 0.1% |
| 6 | Tudor Investment Corporation10 funds on PPLI.com | USD 12m | 0.0% |
| 7 | Exoduspoint Capital Management7 funds on PPLI.com | USD 11m | 0.1% |
| 8 | Millennium Management6 funds on PPLI.com | USD 11m | 0.0% |
| 9 | Renaissance Technologies13 funds on PPLI.com | USD 6.5m | 0.0% |
| 10 | Marshall Wace LLP84 funds on PPLI.com | USD 6.3m | 0.0% |
| 11 | Polar Asset Management Partners6 funds on PPLI.com | USD 5.8m | 0.1% |
| 12 | Citadel Advisors32 funds on PPLI.com | USD 3.9m | 0.0% |
| 13 | Squarepoint Ops7 funds on PPLI.com | USD 2.2m | 0.0% |
| 14 | Capital Fund Management S.A.12 funds on PPLI.com | USD 1.8m | 0.0% |
| 15 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 1.1m | 0.0% |
| 16 | Voleon Capital Management13 funds on PPLI.com | USD 989,000 | 0.0% |
| 17 | Bridgewater Associates45 funds on PPLI.com | USD 860,000 | 0.0% |
| 18 | Engineers Gate Manager1 fund on PPLI.com | USD 699,000 | 0.0% |
| 19 | Capricorn Fund Managers8 funds on PPLI.com | USD 487,000 | 0.0% |
| 20 | Jain Global1 fund on PPLI.com | USD 426,000 | 0.0% |
| 21 | Aquatic Capital Management3 funds on PPLI.com | USD 271,000 | 0.0% |
| 22 | Mirabella Financial Services LLP10 funds on PPLI.com | USD 236,000 | 0.0% |
| 23 | Bayforest Capital1 fund on PPLI.com | USD 32,261 | 0.0% |
| 24 | The Quarry1 fund on PPLI.com | USD 3,368 | 0.0% |
| 25 | Elequin Capital2 funds on PPLI.com | USD 1,051 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Blue Water Life Science Advisors | USD 22m | 13.6% |
| 2 | Viking Global Investors | USD 643m | 1.8% |
| 3 | Perceptive Advisors | USD 26m | 0.4% |
| 4 | Freestone Grove Partners | USD 19m | 0.1% |
| 5 | Polar Asset Management Partners | USD 5.8m | 0.1% |
| 6 | Exoduspoint Capital Management | USD 11m | 0.1% |
| 7 | D. E. Shaw & Co. | USD 99m | 0.0% |
| 8 | Capricorn Fund Managers | USD 487,000 | 0.0% |
| 9 | Bayforest Capital | USD 32,261 | 0.0% |
| 10 | Mirabella Financial Services LLP | USD 236,000 | 0.0% |
Adaptive Biotechnologies Corp trades under the symbol ADPT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 00650F109.
25 of the 720 hedge fund managers PPLI.com tracks reported Adaptive Biotechnologies Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Viking Global Investors (USD 643m), D. E. Shaw & Co. (USD 99m), Perceptive Advisors (USD 26m), Blue Water Life Science Advisors (USD 22m) and Freestone Grove Partners (USD 19m).
25 managers in our coverage reported it, and between them they run 321 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Blue Water Life Science Advisors, where the position was 13.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Adaptive Biotechnologies Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.